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Abstract
NADPH oxidase is a crucial enzyme in mediating antimicrobial host defense and in regulating inflammation. Patients with
chronic granulomatous disease, an inherited disorder of NADPH oxidase in which phagocytes are defective in generation of
reactive oxidant intermediates (ROIs), suffer from life-threatening bacterial and fungal infections. The mechanisms by which
NADPH oxidase mediate host defense are unclear. In addition to ROI generation, neutrophil NADPH oxidase activation is
linked to the release of sequestered proteases that are posited to be critical effectors of host defense. To definitively
determine the contribution of NADPH oxidase versus neutrophil serine proteases, we evaluated susceptibility to fungal and
bacterial infection in mice with engineered disruptions of these pathways. NADPH oxidase-deficient mice (p47phox2/2) were
highly susceptible to pulmonary infection with Aspergillus fumigatus. In contrast, double knockout neutrophil elastase
(NE)2/26cathepsin G (CG)2/2 mice and lysosomal cysteine protease cathepsin C/dipeptidyl peptidase I (DPPI)-deficient
mice that are defective in neutrophil serine protease activation demonstrated no impairment in antifungal host defense. In
separate studies of systemic Burkholderia cepacia infection, uniform fatality occurred in p47phox2/2 mice, whereas NE2/2
6CG2/2 mice cleared infection. Together, these results show a critical role for NADPH oxidase in antimicrobial host defense
against A. fumigatus and B. cepacia, whereas the proteases we evaluated were dispensable. Our results indicate that NADPH
oxidase dependent pathways separate from neutrophil serine protease activation are required for host defense against
specific pathogens.
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Introduction
Chronic granulomatous disease is an inherited disorder of the
NADPH oxidase in which phagocytes are defective in generation
of superoxide anion and downstream reactive oxidant intermedi-
ates (ROIs). As a result of this defect, CGD patients suffer from
recurrent life-threatening bacterial and fungal infections [1].
Among CGD patients, the degree of impairment of NADPH
oxidase in neutrophils correlates with clinical disease severity [2].
Although the critical role of the phagocyte NADPH oxidase has
been established for decades [3], the precise mechanisms by which
NADPH oxidase mediates antimicrobial host defense are not well
understood.
One mechanism by which NADPH oxidase can kill or injure
pathogens is through the direct toxic effects of ROIs. The rapid
activation of NADPH oxidase constitutes an emergency response
to invading pathogens, and occurs in response to several stimuli
such as formylated peptides, opsonized particles, integrin-depen-
dent adhesion [4,5], and ligation of specific pathogen recognition
receptors (e.g., dectin-1 [6]). Syk and class IA phosphoinositide 3-
kinases regulate neutrophil NADPH oxidase activation by
Aspergillus fumigatus hyphae [7]. Upon activation of the oxidase,
the cytoplasmic subunits p47phox, p67phox, and p40phox and Rac
translocate to the membrane-bound heterodimer cytochrome
comprised of gp91phox and p22 phox. Molecular oxygen is converted
to superoxide anion, which can spontaneously or enzymatically be
converted to cytotoxic metabolites, including H202, hydroxyl
anion, and peroxynitrite anion. In neutrophils, myeloperoxidase
catalyzes the conversion of H202 to hypohalous acid, which is
potently microbicidal.
In addition to the direct injurious effect of ROIs against
pathogens, NADPH oxidase may mediate host defense by
activation of pre-formed neutrophil serine proteases. In resting
neutrophils, the flavocytochrome subunits gp91phox and p22phox are
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principally located within the membrane of the secondary granules
[8,9]. Primary (azurophilic) and secondary granules fuse with the
phagocytic vacuole, where their constituents can co-mingle.
Reeves et al. [10] proposed that NADPH oxidase-dependent
killing activity of neutrophils is primarily mediated by activation of
neutrophil granular proteases [10]. They found that neutrophil
NADPH oxidase activation leads to accumulation of ROIs within
phagocytic vacuoles that is coupled to K+ influx and alkalinization
of vacuoles [10]. In their model, changes in ionic concentration
within vacuoles lead to solubilization and activation of antimicro-
bial neutrophil serine proteases, which, at rest, are held in an
inactivated state within primary granules of neutrophils [10].
Neutrophil elastase (NE)-deficient mice have been shown to
have an increased susceptibility to Gram-negative bacterial sepsis
[11]. One mechanism by which NE can mediate host defense is by
cleavage of pathogen virulence factors [12,13]. While cathepsin-G
(CG)-deficient mice have no obvious host defense defect to
bacterial pathogens [14], the double knockout NE2/26CG2/2
mice have reported deficits in both antibacterial and antifungal
host defense [10,15], leading investigators to posit that activation
of neutrophil serine proteases is the major mechanism by which
NADPH oxidase mediates host defense.
Neutrophil serine proteases, NE, CG, and proteinase 3 are
synthesized as zymogens and their activation requires N-terminal
processing activity of the lysosomal cysteine protease cathepsin C/
dipeptidyl peptidase I (DPPI) [16]. Papillon-Lefe`vre syndrome, a
rare autosomal recessive disease resulting from loss-of-function
mutations in the DPPI gene locus, is characterized by palmoplan-
tar hyperkeratosis, periodontitis leading to loss of teeth, and severe
bacterial infections, including liver abscesses [16,17]. A case of
hepatic zygomycosis was reported in a patient with Papillon-
Lefe`vre syndrome [18], pointing to a role for DPPI in antifungal
host defense.
Taken together, there is evidence in humans and mice that
NADPH oxidase and neutrophil serine proteases contribute
critically to host defense. To definitively determine the relative
contribution of NADPH oxidase versus neutrophil serine proteases
against specific pathogens, we evaluated susceptibility of mice with
engineered disruptions of these pathways when challenged with a
clinical isolate of Aspergillus fumigatus or Burkholderia cepacia, two
major pathogens encountered in CGD patients [19,20,21,22,23].
We found that protease-deficient mouse models did not recapit-
ulate the severe immune impairment in CGD mice, and, in fact,
demonstrated no obvious susceptibility to the tested pathogens
compared to wildtype (WT) mice. Thus, our results suggest that
NADPH oxidase directly mediates host defense against specific
pathogens through neutrophil serine protease-independent path-
ways.
Results
Neutrophil elastase2/26cathepsin G2/2 mice have intact
host defense in pulmonary aspergillosis, whereas NADPH
oxidase-deficient p47phox2/2 mice succumb to infection
Invasive aspergillosis is a major cause of morbidity and
mortality in CGD patients [19,20,21,22,23], and NADPH
oxidase-deficient mice are similarly highly susceptible to experi-
mental aspergillosis [24,25,26,27,28]. Prior studies showed that
NE2/26CG2/2 mice also had increased susceptibility compared
to WT mice in a model of systemic aspergillosis [15]. We therefore
asked whether NADPH oxidase-mediated antifungal host defense
principally occurs via neutrophil serine protease-dependent
pathways.
To address this question, we evaluated experimental aspergil-
losis in 3 groups of mice: 1) WT (C57BL/6) mice; 2) p47phox2/2
(CGD) mice; and 3) NE2/26CG2/2 mice. Prior studies from our
and other laboratories showed that WT C57BL/6 mice can clear
an intratracheal inoculum of A. fumigatus .107 conidia (spores) per
mouse [25,29]. In contrast, we previously found that the LD50 in
unmanipulated p47phox2/2 mice is ,104 conidia/mouse [25]. We
therefore selected a high inoculum (1.256107 conidia/mouse) and
a low inoculum (1.256104 conidia/mouse) to evaluate suscepti-
bility to aspergillosis.
Following oropharyngeal challenge with 1.256104 conidia/
mouse, all CGD mice died by 12 days, whereas WT and NE2/2
6CG2/2 mice had uniform survival (Figure 1A). When
administered the high inoculum (1.256107 conidia/mouse), all
CGD mice died within 3 days, whereas all WT and NE2/2
6CG2/2 mice survived (Figure 1B). Thus, the LD50 of the A.
fumigatus inoculum is more than 1000-fold greater in NE2/2
6CG2/2 mice versus CGD mice.
Since we established that NE and CG deficiency does not
recapitulate the CGD phenotype in experimental pulmonary
aspergillosis, our subsequent experiments focused on evaluating
Figure 1. Kaplan-Meier survival curves of WT, p47phox2/2, and
NE2/26CG2/2 mice after administration of A. fumigatus. Mice
were administered A) 1.256104 conidia or B) 1.256107 conidia by
oropharyngeal aspiration. n = 5 mice per genotype per treatment. Log-
rank analysis, p,0.0001 comparing WT with p47phox2/2 mice and NE2/2
6CG2/2 mice with p47phox2/2 mice.
doi:10.1371/journal.pone.0028149.g001
NADPH Oxidase and Neutrophil Proteases
PLoS ONE | www.plosone.org 2 December 2011 | Volume 6 | Issue 12 | e28149
host defense responses in NE2/26CG2/2 mice compared to WT
mice. WT and NE2/26CG2/2 mice administered a high A.
fumigatus inoculum (1.256107 conidia/mouse) were sacrificed on
day 3. BALF leukocytosis and extent of lung inflammation were
similar between the two genotypes (Figure 2A and B). Lung
histology showed a consistent pattern in both genotypes,
characterized predominantly by peribronchovascular inflamma-
tion (Figure 2 C–F). The inflammatory cell type was mixed,
consisting of neutrophils, macrophages and lymphocytes. With
GMS staining, we could not identify invasive parenchymal hyphae
in any of the lung sections. However, there appeared to be hyphal
fragments and debris within inflammatory lesions. Taken together,
Figure 2. Lung histology and airway inflammation in WT and NE2/26CG2/2 mice after A. fumigatus administration. Mice were
administered A. fumigatus (1.256107 conidia per mouse) by oropharyngeal aspiration and sacrificed on day 3. A) BALF leukocyte recovery and B)
percent lung inflammation were similar in WT and NE2/26CG2/2 mice. Representative lung histology from WT (C and D) and NE2/26CG2/2 mice (E
and F). Predominantly peribronchovascular neutrophilic and lymphohistiocytic inflammation occurred in both genotypes (C and E; H&E, 406). GMS
staining (4006) of lung sections from WT (D) and NE2/26CG2/2 (F) mice showed what appeared to be degenerated hyphal fragments, but no
evidence of intact invasive hyphae. Results are representative of 15 WT and 10 NE2/26CG2/2 mice. By comparison, p47phox2/2 mice administered A.
fumigatus at 0.1% of this inoculum (1.256104 conidia per mouse) and sacrificed on day 3 had evidence of fungal pneumonia characterized by G)
multiple foci of neutrophilic consolidation (H&E, 406), and H) hyphal parenchymal invasion (arrow) (GMS, 4006).
doi:10.1371/journal.pone.0028149.g002
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we could not identify a clear difference in airway or parenchymal
inflammation between the genotypes, and, by histological criteria,
both genotypes were able to prevent invasive fungal disease. In
contrast, p47phox2/2 mice administered a low inoculum (1.256104
conidia/mouse) developed neutrophilic consolidative lesions
associated with invasive fungal disease (Figure 2G and H).
We next performed a more detailed assessment of fungal
burden, comparing WT and NE2/26CG2/2 mice on day 3
following A. fumigatus (1.256107 conidia/mouse) challenge. There
was no significant difference in quantitative fungal cultures of
lungs nor was there a difference in serum or BALF galactomannan
levels between the genotypes (Figure 3 A–C). Thus, our data point
to a dispensable role of NE and CG in host defense against
pulmonary aspergillosis.
We considered the possibility that other neutrophil serine
proteases may compensate for the lack of NE and CG levels. DPPI
is required for the full activation of neutrophil serine proteases,
NE, CG, and proteinase 3. Neutrophils from DPPI2/2 mice have
severe deficiency of these proteases [30]. We administered A.
fumigatus (1.256107 conidia/mouse) to WT and DPPI2/2 mice
and assessed lung histology on day 3. Lung inflammation was mild
in both genotypes, predominantly confined to peribronchovascular
areas (Figure 4A and B). Similar to NE2/26CG2/2 mice, we did
not find evidence of hyphal parenchymal invasion in DPPI2/2
mice (Figure 4C and D). Thus, using two different neutrophil
protease-deficient models, we did not identify a role for these
proteases in host defense against pulmonary aspergillosis.
NADPH is required, but neutrophil elastase and
cathepsin G are dispensable, in defense against systemic
Burkholderia cepacia
We next considered whether NE and CG are required for host
defense against systemic B. cepacia challenge. B. cepacia was selected
specifically because it is an important bacterial pathogen in
patients with CGD [22,23] (and patients with cystic fibrosis), but
generally not in other immunocompromised patients such as those
with prolonged neutropenia or receiving immunosuppressive
therapy. Studies of human neutrophils show that killing of B.
cepacia is NADPH oxidase-dependent [31], and CGD mice have
increased susceptibility to B. cepacia challenge [28,32,33,34]. Thus,
B. cepacia infection is an excellent model to evaluate NADPH
oxidase-dependent antibacterial host defense.
WT, p47phox2/2 and NE2/26CG2/2 mice were administered
intraperitoneal 46107 colony forming units (CFUs) of B. cepacia,
and time to mortality was followed. Mortality occurred within 4 to
6 days following challenge in p47phox2/2 mice, whereas all WT
and NE2/26CG2/2 mice survived (Figure 5A). In separate
experiments, mice were administered B. cepacia (46107 CFU),
sacrificed at 24 h, and quantitative cultures were performed on
blood, peritoneum, kidneys and spleens. Blood cultures from the
three genotypes showed no growth. Bacterial recovery from
peritoneal cavities and spleens was significantly greater in
p47phox2/2 mice compared to WT and NE2/26CG2/2 mice
(Figure 5B). Thus, similar to A. fumigatus, NADPH oxidase was
critical in host defense against B. cepacia, while NE and CG were
dispensable.
Discussion
Our results show that NADPH oxidase is essential in defending
against A. fumigatus and B. cepacia, but does so independently of
neutrophil serine proteases. In two models of engineered protease-
deficient mice, host defense was intact against A. fumigatus and B.
cepacia, two major pathogens in CGD patients. These results do not
exclude the possibility that neutrophil serine proteases may have a
more central role in host defense against other pathogens that
cannot be compensated by NADPH oxidase-dependent pathways.
Figure 3. Fungal burden in WT and NE2/26CG2/2 mice after A.
fumigatus administration. Mice were administered A. fumigatus
(1.256107 conidia per mouse) by oropharyngeal aspiration and
sacrificed on day 3. A) Quantitative fungal cultures in lung homoge-
nates, B) serum galactomannan, C) BALF galactomannan. n = 10 mice
per genotype subjected to infection (A. fum), and n=1 mouse per
genotype subjected to sham-infection. No significant differences
occurred in quantitative lung fungal cultures, serum galactomannan,
and BALF galactomannan between Aspergillus-infected WT mice and
NE2/26CG2/2 mice.
doi:10.1371/journal.pone.0028149.g003
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Our results support a model in which NADPH oxidase and
neutrophil serine proteases have distinct antibacterial and
antifungal effector functions rather than protease activation being
the central mechanism by which NADPH oxidase mediates host
defense.
Consistent with this notion, patients with CGD and Papillon-
Lefe`vre syndrome (who lack functional DPPI) suffer from
recurrent infections, but the spectrum of pathogens differs between
the two diseases. An important consideration is that defects in
neutrophil-mediated killing in ex vivo studies may not be
recapitulated in vivo regarding susceptibility to infection. In
addition, neutrophil serine protease deficiency may be compen-
sated for by other neutrophil effector pathways. Bianchi et al. [35]
identified calprotectin as a NET constituent mediating anti-
Aspergillus host defense. Indeed, neutrophils are armed with several
antimicrobial agents, including lactoferrin [36], lysozyme, and
defensins. Potentially, NADPH oxidase-induced serine protease
activation may be important for defense against certain pathogens
but play a redundant role in defense against others.
There may also be pathogen-related differences that influence
susceptibility to neutrophil proteases. Belaaouaj et al. [11] showed
an important function of neutrophil elastase in defending against
certain Gram-negative (Klebsiella pneumoniae and Escherichia coli) but
not Gram-positive (Staphylococcus aureus) bacteria in mice. However,
neutrophils from patients with Papillon-Lefe`vre syndrome (who
lack functional DPPI) do not have a uniform defect in killing
Staphylococcus aureus and Escherichia coli, suggesting that neutrophil
serine proteases may not be the major pathway used by human
neutrophils to kill specific bacteria [16]. In addition, our
experiments focused on acute infection models with early time
points for analysis. Potentially, we may have identified differences
in host defense between wildtype and protease-deficient mice had
we included higher inocula of pathogens and/or different time
points for analysis.
Tkalcevic et al. [15] previously showed that NE2/26CG2/2
mice were more susceptible to intravenous A. fumigatus adminis-
tration compared to WT mice based on survival and fungal
burden in kidneys. This apparent discrepancy with our findings is
likely in part related to the route of Aspergillus administration. We
used oropharyngeal aspiration because inhalation is by far the
most common portal of entry of Aspergillus species. There are likely
critical features of pulmonary host defense that are not reflected in
the intravenous model. For example, inhaled conidia are
phagocytosed by alveolar macrophages, where NADPH oxidase
can play a role in restricting germination of A. fumigatus conidia
[37]. Neutrophil elastase and cathepsin G can promote coagula-
tion and intravascular thrombus growth in vivo that restricts tissue
bacterial invasion [38]; conceivably, this pro-thrombogenic effect
of neutrophil proteases may limit tissue invasion of intravenously
administered fungus, but be less relevant following intrapulmonary
challenge. Another difference is the strains of mice used for the
studies: we used NE2/26CG2/2 mice backcrossed to C57BL/6
whereas the mice used by Tkalcevic et al. [15] were backcrossed to
the 129Sv strain. There can be important mouse strain-specific
differences in susceptibility to aspergillosis [39] that can influence
the relative importance of specific host defense pathways.
Neutrophil serine proteases have also been shown to contribute
to pathogen killing through formation of neutrophil extracellular
traps (NETs). Upon activation, neutrophils release granule
proteins and chromatin that co-mingle in the extracellular
environment to form NETs. These NETs bind to and kill bacteria
and degrade bacterial virulence factors [40], and target fungi
[41,42]. Release of NETs requires death of neutrophils and
breakdown of cell membranes, and has been linked to NADPH
oxidase activation and autophagy [43,44]. NADPH oxidase-
mediated NET formation involves complex intracellular signaling,
including activation of the Raf-MEK-ERK and upregulation of
antiapoptotic proteins [45], and production of interferon-gamma
Figure 4. Lung histology in WT and DPPI2/2 mice on day 3 after oropharyngeal A. fumigatus (1.256107 conidia per mouse)
administration. In both WT (A) and DPPI2/2 (B) mice, mild predominantly peribronchovascular inflammation occurred (H&E, 1006). No evidence of
invasive hyphae was present with GMS staining (4006) in either WT (C) or DPPI2/2 (D) mice. n = 5 mice per genotype.
doi:10.1371/journal.pone.0028149.g004
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[46]. NET formation was dependent on neutrophil elastase and
myeloperoxidase in a mouse model of bacterial pneumonia [47].
Although neutrophils from CGD patients are deficient in NET
formation [44], the dependence on NADPH oxidase for NET
generation appears to be stimulus-dependent rather than a
uniform requirement [48,49]. Further studies are required to
delineate the precise role of NADPH oxidase in NET generation
and the role of NETs in NADPH oxidase-dependent pathogen
killing.
Histological lung inflammation was similar between WT and
neutrophil protease-deficient mice following A. fumigatus challenge,
a finding that suggests that neutrophil serine proteases do not play
a major role in regulating the inflammatory response in this
infection model. Prior studies have shown that activation of
neutrophil proteases generally leads to augmented inflammation
and tissue injury [30,50,51,52,53]. Although NADPH oxidase
activation leads to generation of cytotoxic ROIs, paradoxically,
NADPH oxidase limits inflammation and injury in several models
[54,55,56,57,58,59]. This protective role of NADPH oxidase is
likely mediated by modulation of redox-sensitive targets that
regulate inflammation and cytoprotective pathways, such as Nrf2
[55]. These results further demonstrate the distinct roles of
NADPH oxidase and proteases in modulating inflammation and
injury.
NADPH oxidase is a critical regulator of antibacterial and
antifungal host defense and of inflammation. Studies of protease-
deficient mice and patients with Papillon-Lefe`vre syndrome point
to neutrophil proteases also having an important host defense
function. These results and those of our study support a model in
which NADPH oxidase-regulated antimicrobial pathways have
distinct pathogen-specific functions in which certain pathogens are
sensitive to the direct antimicrobial effect of ROIs whereas others




All procedures performed on animals in this study were
approved by the Animal Care and Use Committee at Roswell
Park Cancer Institute, and complied with all state, federal, and
NIH regulations.
Mice
Mice with a targeted disruption of the p47phox gene have a defective
NADPH oxidase, rendering phagocytes incapable of generating
measurable superoxide [60]. NADPH oxidase-deficient mice have
increased susceptibility to pathogens that afflict CGD patients,
including Aspergillus species [24,25,27] and B. cepacia [28,32,33,34].
p47phox2/2 mice were derived from C57BL/6 and 129 intercrosses,
and backcrossed 14 generations (N14) in the C57BL/6 background.
NE2/2 mice [11] and CG2/2 mice [14] were intercrossed to
generate double knockout NE2/26CG2/2mice (N10 in C57BL/6)
[51]. Dipeptidyl peptidase I (DPPI) is a lysosomal cysteine protease
required for the activation of granule-associated serine proteases,
including NE, CG, and proteinase 3. DPPI2/2 mice (N11 in
C57BL/6) were generated as previously described [30]. Microsatel-
lite typing performed at the Washington University Rheumatic
Disease Core Center’s Speed Congenics Laboratory showed the
NE2/26CG2/2 mice and DPPI2/2 mice to be 97.7% and 99.2%
C57BL/6, respectively. Age (8–15 weeks) and sexmatched C57BL/6
WT mice were used as controls. Mice were bred and maintained
under specific pathogen free conditions at the animal care facility at
Roswell Park Cancer Institute, Buffalo, NY.
Administration of A. fumigatus
A clinical isolate of A. fumigatus was used in all experiments [25].
Conidial suspensions were prepared as previously described [25],
diluted to desired concentrations, and administered by oropha-
ryngeal aspiration. We found that oropharyngeal aspiration leads
to similar degrees of fungal pneumonia and mortality in p47phox2/2
mice compared to intratracheal administration, but avoids surgery.
Mice were anesthetized by isofluorane inhalation using an approved
chamber. Following anesthesia, mice were suspended by their upper
incisors from a suture thread on a 90u incline board. The tongue was
gently extended, and a liquid volume (maximum 50 ml) was delivered
into the distal part of the oropharynx. With the tongue extended, the
animal was unable to swallow, and the liquid volume was aspirated
into the lower respiratory tract. Just prior to liquid delivery, the chest
was gently compressed and then released just after deposition of
liquid into the oropharynx to enhance aspiration of the liquid into the
lung. Mice recovered within 5 minutes of the procedure, and were
observed until they resumed normal activity.
Bronchoalveolar fluid collection and cytology
After sacrifice, BALF collection was performed as previously
described [55]. The trachea was cannulated with a 22-gauge i.v.
catheter. Using a tuberculin syringe, 1000 mL PBS was injected
Figure 5. WT mice and NE2/26CG2/2 mice were resistant to
Burkholderia cepacia infection, whereas p47phox2/2 mice were
highly susceptible. A) Kaplan-Meier survival curves in WT, p47phox2/2
and NE2/26CG2/2 mice administered intraperitoneal B. cepacia (46107
CFUs/mouse). Log-rank analysis, p,0.0002 comparing WT with
p47phox2/2 mice and p,0.0002 comparing NE2/26CG2/2 mice with
p47phox2/2 mice. n = 10 mice per genotype. B) In separate experiments,
mice (n = 5 per genotype) were administered the same inoculum of B.
cepacia, and quantitative cultures were performed at 24 h. WT and NE2/2
6CG2/2mice cleared infection, whereas bacterial infection persisted in the
peritoneum and spleens of p47phox2/2 mice. Circles, no growth.
*, p,0.03; **, p,0.01.
doi:10.1371/journal.pone.0028149.g005
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and withdrawn from the lung and again fresh 1000 mL PBS was
injected and withdrawn from the lung and both were pooled. Cells
were pelleted by centrifugation at 1,500 g for 3 min. Supernatants
were aliquoted and stored at 280uC. In the cell pellet, the red
blood cells (RBCs) were removed by ACK lysis, and the cells were
suspended in 1 ml of PBS. The total number of leukocytes/ml was
counted using a hemocytometer. Cells were then cytocentrifuged
onto clean glass slides and stained with the Hema 3 stain set
(Fisher Scientific, Pittsburgh, PA, USA), and cell differential counts
were assessed blinded to genotype.
Histopathology
After sacrifice and bronchoalveolar lavage, mouse lungs were
infused with 10% neutral buffered formalin via the trachea.
Paraffin-embedded blocks were prepared and sections were
stained with Hematoxylin and Eosin (H&E) to assess inflammation
and Grocott-Gomori methenamine-silver stain (GMS) to visualize
fungi. Tissues were microscopically examined for pulmonary
injury, vascular invasion, and structural changes in Aspergillus
hyphae. All slides were analyzed by one of us (BHS) using 406
magnification without formal morphometric analysis, and blinded
to genotype. The percentage of lung involved by inflammation was
scored in each mouse as follows: 0%, 5%, 10%, and then by 10%
increments (e.g., 20%, 30%, 40%, etc.). The predominant
inflammatory cell type was scored.
Assessment of fungal burden
Fungal burden was assessed in four ways. (i) The presence of
invasive hyphae in lungs was determined by histology. (ii)
Quantitative cultures of lung homogenates were performed using
a previously validated method [61]. Lungs were weighed, placed
in a sterile polyethylene bag (Tekmar Corp., Cincinnati, Ohio),
and homogenized with sterile saline for 30 s (Stomacher 80;
Tekmar Corp., Cincinnati, Ohio). Lung homogenate dilutions
(1021 and 1022) were prepared in sterile saline. Aliquots (100 ml)
from homogenates and homogenate dilutions were plated on
Sabouraud glucose agar plates, incubated at 37uC for the first
24 h, and then left at room temperature for another 24 h. The
number of colony forming units (CFUs) of A. fumigatus was
counted, and the CFUs per gram was calculated. A finding of one
colony of A. fumigatus was considered positive. (iii) Galactomannan
is a fungal cell wall product. The serum concentration of
galactomannan is directly related to the concentration of A.
fumigatus in lung tissue of experimental invasive pulmonary
aspergillosis [62,63]. Detection of galactomannan is used clinically
as a diagnostic adjunct for invasive aspergillosis [64]. Batched
frozen serum samples from infected and sham-infected mice were
thawed, and galactomannan levels were quantitated using Platelia
Aspergillus enzyme immunoassay (Bio-Rad Laboratories, Red-
mond, WA) per the manufacturer’s instructions. (iv) BALF
galactomannan levels were determined using the same assay.
Galactomannan concentrations in BALF also correlate directly
with concentrations of A. fumigatus in lung tissue [65].
Administration of Burkholderia cepacia
We used a B. cepacia strain isolated from a CGD patient [33].
Bacteria were stored in Lennox broth (Invitrogen) at 280uC until
use. Aliquots of frozen bacteria were thawed, inoculated into
Lennox broth, and grown with shaking at 37uC overnight. The
bacteria were washed twice in DPBS, and bacterial density was
determined by absorption at 650 nm at dilutions corresponding to
the linear portion of the absorbance-bacterial density curve. To
confirm the bacterial density, aliquots were serially diluted and
sub-cultured in duplicate on Lennox agar plates, and colony
forming units were counted. Mice were injected intraperitoneally
with 0.2 ml of bacteria at the desired concentration. One set of
mice was followed for survival, while bacterial clearance was
assessed 24 hours after challenge in a second set of mice. In this
second set of mice, blood was collected retro-orbitally into Z (no
additive tube) microtainers (BD Biosciences). Peritoneal lavage was
performed with 10 ml of DPBS, and spleens and kidneys were
harvested and homogenized in 2 ml of DPBS. Samples were
diluted in serial 10-fold dilutions and inoculated in duplicate onto
Lennox agar plates. After inoculation, plates were incubated for 24
to 48 h at 37uC and colonies were enumerated.
Time to euthanasia
Following infection, mice were monitored twice daily for death
and morbidity until at least day 25. Mice with pre-specified criteria
for distress that included inability to feed or drink, labored
breathing, or general moribund appearance were euthanized by
CO2 asphyxiation.
Statistical Analysis
Kaplan-Meier curves were generated for each population for
time to euthanasia experiments (Graph Pad Prism 4.0) and
analyzed using the log-rank method. In experiments involving
quantitation of bacterial and fungal burden, inter-group compar-
isons were made using the non-parametric Mann-Whitney
method. In cases in which bacterial cultures were sterile in all
mice in a given group, Wilcoxon Signed Rank test was used for
inter-group comparisons. A two-sided p value of ,0.05 was
considered to be statistically significant.
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